DexCom, Inc. Share Price Deutsche Boerse AG
Equities
DC4
US2521311074
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
109.2 EUR | -6.54% | -5.68% | -2.48% |
30/05 | Redburn Atlantic Initiates DexCom With Neutral Rating, $130 Price Target | MT |
24/05 | Declaration of Voting Results by DexCom, Inc | CI |
Sales 2024 * | 4.33B 3.99B 361B | Sales 2025 * | 5.15B 4.75B 430B | Capitalization | 47.23B 43.55B 3,940B |
---|---|---|---|---|---|
Net income 2024 * | 732M 675M 61.06B | Net income 2025 * | 910M 839M 75.9B | EV / Sales 2024 * | 11.2 x |
Net Debt 2024 * | 1.43B 1.32B 120B | Net Debt 2025 * | 994M 917M 82.93B | EV / Sales 2025 * | 9.36 x |
P/E ratio 2024 * |
65.7
x | P/E ratio 2025 * |
53.7
x | Employees | 9,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.62% |
Latest transcript on DexCom, Inc.
1 day | -6.54% | ||
1 week | -5.68% | ||
1 month | -6.76% | ||
3 months | +4.54% | ||
6 months | +3.27% | ||
Current year | -2.48% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Sayer
CEO | Chief Executive Officer | 66 | 01/07/01 |
Jereme Sylvain
DFI | Director of Finance/CFO | 44 | 01/18/01 |
Chief Tech/Sci/R&D Officer | 47 | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nick Augustinos
BRD | Director/Board Member | 65 | 20/09/20 |
Mark Foletta
BRD | Director/Board Member | 63 | 19/14/19 |
Eric Topol
BRD | Director/Board Member | 69 | 09/09/09 |
Date | Price | Change | Volume |
---|---|---|---|
31/24/31 | 109.2 | -6.54% | 0 |
30/24/30 | 116.8 | -0.39% | 0 |
29/24/29 | 117.3 | +0.58% | 464 |
28/24/28 | 116.6 | -1.04% | 655 |
27/24/27 | 117.8 | +1.78% | 8 |
Delayed Quote Deutsche Boerse AG, May 31, 2024 at 11:50 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B | |
-5.38% | 23.69B |
- Stock Market
- Equities
- DXCM Stock
- DC4 Stock